View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Atezolizumab 840 / Doxorubicin 60 / Cyclophosphamide 600, Breast Cancer, neoadjuvant, cycle 4-5.
Protocol-ID: 2424 V1.0 (Mini), ATEZ840/DOXO60/CYCL600, Breast Ca, neoadj., C4-5Indication(s)
- Breast Cancer (tripel negative, PD-L1+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 29.08.2023